Alvotech s 2024 plans include several product launches around the world through various partners, but the forthcoming introduction of SIMLANDI® in the U.S. is in a market that is truly in the
India Business News: In Jan, the Indian pharma market saw 8% growth driven by respiratory therapies. Anti-asthma drugs like Foracort had double-digit growth, reflecting po
The revenues for the quarter grew nearly 10% while the net profit rose 16.5%. Both the domestic and US markets reported double-digit growth in revenues. The operating margin (Ebitda margin) rose 140 bps to 28.1%. The company has been charting a strong growth trajectory in recent quarters leading to the stock gaining almost 40% in the past one year.
Global Clinical Trial Supply and Logistics for Pharma Market Set for Strong Growth by 2033 Amid Digitization and Shift to Personalized Medicine tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.